Our COO, James Gaskell has shared his views on the industry, innovation and policy development at the second annual World Cannabis Congress, which took place on the 18th June in Canada. The World Cannabis Congress brings together global cannabis leaders, thought leaders, investors and researchers who exchange their ideas and opinions on the medicinal cannabis industry. Read more about the World Cannabis Congress here.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >